ACADIA Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

CEO

Catherine Owen Adams

CEOCatherine Owen Adams

Employees

654

Employees654

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1993

Founded1993

Employees

654

Employees654

ACAD Key Statistics

Market cap

4.29B

Market cap4.29B

Price-Earnings ratio

19.30

Price-Earnings ratio19.30

Dividend yield

—

Dividend yield—

Average volume

1.95M

Average volume1.95M

High today

$27.00

High today$27.00

Low today

$25.36

Low today$25.36

Open price

$25.89

Open price$25.89

Volume

750.83K

Volume750.83K

52 Week high

$27.00

52 Week high$27.00

52 Week low

$13.40

52 Week low$13.40

Analyst ratings

65%

of 20 ratings

Buy

65%

Hold

30%

Sell

People also own

Based on the portfolios of people who own ACAD. This list is generated using Robinhood data, and it’s not a recommendation.